Healthcare | June 20, 2026
Quadria-backed HealthQuad closes Rs. 550 crore first close for fund 3
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
Backs Lifesigns in first bet and doubles down on India’s healthcare AI surge
.jpeg)
One of our major priorities in next 3-5 years is the introduction of a kit-based version of CanAssist Breast, enabling hospitals conduct the test locally
Industry veteran with over two decades of experience to lead expansion across India, South Asia, Southeast Asia, and other high-growth healthcare markets
Leading experts from AIIMS Kalyani, Syngene, Veeda Lifesciences, Lambda Therapeutic, DNDi, JSS Medical, KIHT, InoRx, ISCR and SIRO Clintech to discuss India’s readiness as preferred clinical research destination
Since 2022, we have grown threefold and our growth story is built on scale, scientific innovation and deep customer partnerships
Exclusive partnership introduces globally benchmarked stem cell processing platform aimed at improving stem cell recovery, quality, and long-term therapeutic potential
Both nations deepen cooperation in health innovation, AI-driven healthcare, biomedical research, data sharing, and life sciences to accelerate next-generation healthcare solutions
KIHT can now conduct clinical research for drugs and medical devices, strengthening evidence generation and healthcare innovation
The Prayagraj lab is designed to handle both routine and specialised testing
We are building the bridge between complex molecular data and everyday clinical decisions
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
